KIRITSY CHRISTOPHER P — SEC insider filings
SEC reporting owner CIK 1261156. 11 insider filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2021-06-29 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $8,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 313 shares, $49,141 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 313 shares @ $157.00 ($49,141) in PALVELLA THERAPEUTICS, INC., filed 2026-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. (PVLA) | Director | 9 | 1 leg · 10,000 sh · $8,500 | 1 leg · 313 sh · $49,141 | 9 |
| HTG MOLECULAR DIAGNOSTICS, INC (HTGM) | Director | 2 | — | — | 2 |
Insider filings — KIRITSY CHRISTOPHER P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Option exercise (M): 313 @ $127.20 · Sale (S): 313 @ $157 · Option exercise (M): 313 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 12,350 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 24,700 (derivative) @ $0 | EDGAR |
| 2024-12-09 | 4 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/award (A): 500 (derivative) @ $0 | EDGAR |
| 2023-06-23 | 4 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-05-30 | 4 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Purchase (P): 10,000 @ $0.85 | EDGAR |
| 2022-09-15 | 4 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) | Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-01-31 | 4 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-24 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1261156 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs